Princeton Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Princeton Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,923	Closed	-$365K	–	115
2021 Q4	$365K	Sell	3,923 -125	-3%	-$8.23K	0.1%	85
2021 Q3	$241K	Buy	4,048 +102	+3%	+$6.03K	0.08%	97
2021 Q2	$269K	Buy	3,946 +126	+3%	+$8.21K	0.08%	98
2021 Q1	$265K	Hold	3,820	–	–	0.09%	96
2020 Q4	$293K	Hold	3,820	–	–	0.1%	81
2020 Q3	$286K	Hold	3,820	–	–	0.12%	77
2020 Q2	$240K	Buy	+3,820	New	+$210K	0.11%	81
2019 Q4	–	Sell	-625	Closed	-$29K	–	241
2019 Q3	$29K	Hold	625	–	–	0.01%	178
2019 Q2	$37K	Buy	+625	New	+$32.3K	0.02%	166

Princeton Capital Management's ARNA Position: Q1 2022 in Review

Princeton Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,923 shares — an estimated $365K sold.

Princeton Capital Management first reported a position in ARNA in Q2 2019 and held it in 9 quarters. The position peaked at $365K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Princeton Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Princeton Capital Management sold 3,923 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $365K.
Princeton Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 9 quarters.
Princeton Capital Management's Arena Pharmaceuticals Inc position peaked at $365K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Princeton Capital Management's 13F filing for Q1 2022, filed 11 May 2022.